Physician

Martin Palmeri, M.D.,M.B.A.

According to 2025 Medicare claims, Martin Palmeri, M.D., M.B.A. (NPI: 1811005374) practices hematology/oncology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 28806-2316. Palmeri is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Palmeri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 816 traditional Medicare patients, billed 135,487 HCPCS/CPT codes, and received $3,483,967 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,402 prescription claims across 235 beneficiaries totaling $3,576,547 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 399 claims. Open Payments data shows 49 records totaling $4,151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $124,623 to $3,483,967. Similarly, Part D prescription costs have risen steadily, from $840,029 to $3,576,547. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,062 and ending at $956.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	646	5,821	$124,623
2016	591	4,162	$115,736
2017	450	1,039	$77,793
2018	337	709	$55,028
2019	344	806	$60,057
2020	561	106,020	$2,173,478
2021	687	128,680	$2,548,081
2022	709	104,252	$2,044,499
2023	884	115,353	$2,238,122
2024	816	135,487	$3,483,967

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	215	897	$840,029
2016	192	1,133	$1,420,912
2017	183	861	$1,572,789
2018	176	1,002	$1,743,322
2019	200	1,069	$1,708,701
2020	184	732	$1,414,244
2021	177	797	$2,176,691
2022	192	876	$2,310,141
2023	227	1,108	$2,688,068
2024	235	1,402	$3,576,547

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	58	164	$82,301
2016	26	116	$52,584
2017	17	103	$40,289
2018	N/R	106	$16,144
2019	N/R	23	$2,743
2020	35	138	$12,080
2021	26	138	$9,437
2022	53	215	$8,393
2023	58	183	$41,300
2024	66	399	$146,824

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	149	446	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	272	483	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	248	403	$12
36415	Insertion of needle into vein for collection of blood sample	503	1,002	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	544	1,220	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	34	952	$763,347
Revlimid	Lenalidomide	26	728	$452,591
Abiraterone Acetate	Abiraterone Acetate	47	1,410	$279,397
Imbruvica	Ibrutinib	13	364	$246,603
Erleada	Apalutamide	15	450	$223,390

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4197	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix	N	N/R	46	$101,886
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	53	$20,631
B4224	Parenteral nutrition administration kit, per day	N	N/R	52	$10,441
B9004	Parenteral nutrition infusion pump, portable	Y	N/R	12	$5,324
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	52	$3,343

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$4,151	BeiGene USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Martin Palmeri, M.D., M.B.A.?

Tedicare shows public-source Medicare data for Martin Palmeri, M.D., M.B.A. (NPI 1811005374), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Martin Palmeri, M.D., M.B.A. have ACO affiliation data?

Martin Palmeri, M.D., M.B.A. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Martin Palmeri, M.D., M.B.A.?

Martin Palmeri, M.D., M.B.A. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Martin Palmeri, M.D., M.B.A. have Open Payments data?

Martin Palmeri, M.D., M.B.A. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.